Trademarkia Logo

Canada

C$
NUTCRACKER
REGISTERED

on 20 Sept 2023

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

NUTCRACKER THERAPEUTICS INC.

5858 Horton Street, Suite 540Emeryville CA 94608

US

Serial Number

2125053 filed on 17th Mar 2021

Registration Number

TMA1198825 registered on 20th Sept 2023

Registration expiry Date

17th Mar 2031

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

NUTCRACKER

Trademark usage description

active chemical ingredients, including m-rna, for use in the manufacture of anti-cancer drugs; chemical solutions and preparations consisting of pre-m Read More

Classification Information


Class [001]
Active chemical ingredients, including m-RNA, for use in the manufacture of anti-cancer drugs; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with transcription and translation of nucleic acid; chemical solutions and preparations consisting of pre-mixed reactants and reagents used to transfect nucleic acid into cells in the field of scientific research; active chemical ingredients for use in manufacture of anti-cancer drugs; protein arrays and nucleotide arrays for scientific use; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for pharmaceutical manufacturing and scientific purposes.


Classification kind code

11

Class [005]
Macromolecules, namely, nucleic acid sequences and proteins, used for medical purposes; nucleic acid sequences and chemical reagents for medical purposes; protein arrays and nucleotide arrays for medical laboratory use; diagnostic preparations for clinical or medical laboratory use.


Classification kind code

11

Class [009]
Cartridges and DNA chips to receive and preserve biological samples for use in RNA transcription; scientific apparatus and instruments for manufacturing m-RNA and parts and fittings therefore; laboratory apparatus and instruments for transcription of RNA from DNA and translation to m-RNA; scientific apparatus for receiving DNA samples, transcribing RNA, and producing m-RNA molecules for use in identifying and/or manufacturing therapeutic drugs to treat human diseases.


Classification kind code

11

Class [035]
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Compiling of statistical data for research purposes in the field of medical science and medical consultancy; Compiling of data from clinical trials for research purposes in the field of medical science and medical consultancy.


Classification kind code

11

Class [042]
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; DNA analysis services for scientific research purposes; medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; and consulting services for others in the field of design, planning, and implementation of clinical trials; design, engineering, research, development and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics.


Classification kind code

11

Class [044]
Medical services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases and immunological diseases; veterinary services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases, and immunological diseases; medical, veterinary and pharmaceutical consultation; medical and veterinary diagnostic testing, monitoring and reporting services; providing medical information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases; medical services, namely, providing therapies for treating cancer, medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes.


Classification kind code

11

Mark Details


Serial Number

2125053

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 22nd Dec 2022
Agent Changed
Submitted for opposition 22
on 17th Nov 2022
Search Recorded
Submitted for opposition 20
on 17th Nov 2022
Examiner's First Report
Submitted for opposition 223
on 17th Nov 2022
Total Provisional Refusal
Submitted for opposition 256
on 6th Jun 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 5th Aug 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 4th Aug 2021
Created
Submitted for opposition 31
on 4th Aug 2021
Formalized
Submitted for opposition 228
on 17th Mar 2021
International Registration
Submitted for opposition 30
on 17th Mar 2021
Filed